Find Academic Supervisors

Petros Koumoutsakos is the Herbert S. Winokur, Jr. Professor of Computing in Science and Engineering at Harvard University's School of Engineering and Applied Sciences (SEAS), where he also serves as Area Chair for Applied Mathematics. His research integrates machine learning with computational science to advance understanding of complex systems, including fluid dynamics, turbulence modeling, and biomedical applications. He leads the CSE Lab, focusing on high-performance computing and interdisciplinary collaborations such as a recent study with Citadel Securities and Google Cloud to simulate heart disease in cloud environments. Key research interests include reinforcement learning for turbulence closures, generative models for PDE solutions, and physics-informed AI for biomedical imaging and wildfire prediction. He was awarded the PRACE HPC Excellence Award (2023) for contributions to high-performance computing. His work bridges computational methods with real-world applications, emphasizing interpretability and scalability in multiscale systems. Grants & Collaborations: Leadership in multi-institutional projects, including turbulence modeling via reinforcement learning and cloud-based HPC studies. Labs/Teams: Director of the CSE Lab, advancing AI, computational fluid dynamics, and biomedical simulations.

• Machine Learning
• Computational Fluid Dynamics
• Turbulence Modeling
• +3 more

Qianwen Wang is a tenure-track Assistant Professor in the Computer Science department at the University of Minnesota, Twin Cities. Her research combines interactive visualization with interpretable machine learning to foster intuitive, efficient, and reliable Human-AI collaboration. She actively seeks motivated students, research assistants, and interns to join her dynamic research team at UMN CS. Dr. Wang's research focuses on three primary themes: Human-AI Collaboration, where she designs tools to facilitate Human-AI interaction; Automatic & Intelligent Visualization, where she develops techniques to make visualizations accurately interpreted and easily used; and VIS+(X)AI in Biomed/Healthcare, where she studies how visualization and explainable AI can promote scientific discoveries in biomedicine and healthcare. Her work has made significant contributions to visualization, human-computer interaction, and bioinformatics, with particular applications in biomedical knowledge graphs and single-cell omics analysis. Her recent publications demonstrate a strong trend toward integrating visualization with large language models and graph neural networks for biomedical applications. She has published extensively at top venues including IEEE VIS, ACM CHI, and Nature Medicine, with a focus on making AI systems more interpretable and useful for domain experts, particularly in healthcare contexts. Her work often bridges theoretical advances in visualization with practical applications in genomics and healthcare. Two IEEE VIS Honorable Mention Awards (2022, 2024) Best Paper Award from IMLH@ICML 2021 Two Best Abstract Awards from BioVis ISMB (2021, 2022) HDSI Postdoctoral Research Fund Award Research covered by MIT News and Nature Technology Features Dr. Wang actively contributes to the academic community through service roles including General Chair for ISMB BioVis, VisNotes and Poster Chair for IEEE PacificVis, and Program Committee member for IEEE VIS, ACM CHI, and ACM IUI. Her research has been supported by various grants that enable her team to develop innovative visualization techniques and explore their practical applications in biomedical domains. Her research group maintains an active presence in the visualization and HCI communities, with members participating in major conferences and workshops. The lab focuses on creating tools that bridge the gap between complex AI models and human understanding, with particular emphasis on making these technologies accessible and useful for domain experts in biomedical research.

• Interactive Visualization
• Interpretable Machine Learning
• Human-AI Collaboration
• +5 more

Professor Jiyuan Tu is a Professor in the Department of Mechanical and Automotive Engineering at RMIT University's School of Engineering. He specializes in computational fluid dynamics (CFD), multiphase flows, and their applications in renewable/nuclear energy, biomedical engineering, and built environment systems. His research has led to over 500 peer-reviewed articles, 9 books, and $10M+ in ARC grants. He has supervised over 50 postgraduate students and received prestigious awards such as the RMIT Research Excellence Award (2012) and Fulbright Senior Scholar Award (2008). Research interests include CFD modelling of bioaerosol transport, drug delivery systems, and thermal energy storage. He pioneered numerical models for multiphase flows, contributing to software implementations in industries. Notable works include books on CFD and multiphase flow analysis, and leadership in international conferences like COBEE 2018. He holds honorary professorships at Tsinghua University and is Editor-in-Chief of the Experimental and Computational of Multiphase Flow journal. Industry experience includes roles at ANSTO (1996-2001). Awards span fellowships from JSPS, KOSEF, and Fulbright programs. Grants include ARC Discovery, Linkage, and LIEF projects. His work ranks him among the world’s top researchers in pebble bed reactors and airborne infection studies (SciVal 2016-2025).

• Computational Fluid Dynamics (CFD)
• Multiphase Flows
• Thermal Sciences
• +4 more

Geoffrey Pleiss is an Assistant Professor in the Department of Statistics at the University of British Columbia's Faculty of Science. He is also a CIFAR AI Chair at the Vector Institute and an inaugural member of CAIDA's AIM-SI (AI Methods for Scientific Impact) cluster. His work bridges statistical theory, machine learning, and computational methods with applications across various scientific domains. Pleiss received his PhD from the Computer Science department at Cornell University in 2020, where he was advised by Kilian Weinberger and worked closely with Andrew Gordon Wilson. Prior to his faculty position at UBC, he was a postdoctoral researcher at Columbia University with John P. Cunningham. His research focuses on the intersection of deep learning and probabilistic modeling, particularly on developing heuristic and approximate notions of uncertainty from machine learning models. His work has significant implications for reliable and optimal decision-making in experimental design and scientific discovery. Major research thrusts include neural network uncertainty quantification, Bayesian optimization, Gaussian processes, and ensemble methods. Pleiss develops theoretical frameworks while maintaining strong connections to practical applications across scientific domains. An analysis of his recent publications reveals a strong focus on uncertainty quantification in deep learning models, with particular attention to the limitations and capabilities of ensemble methods in the era of overparameterized models. His work increasingly addresses practical challenges in Bayesian optimization for scientific discovery, especially in materials science. There's also a growing emphasis on computational efficiency in Gaussian process methods, reflecting his commitment to making advanced statistical techniques accessible for real-world applications. CIFAR AI Chair Pleiss currently advises several graduate students including Donney Fan (PhD, Computer Science), Tim G. Zhou (MSc, Computer Science), Zachary Lau (MSc, Statistics), Nathan Cantafio (BSc, Statistics), and Tristan Cinquin (Research Intern at Vector Institute). His research is supported by multiple funding sources including his CIFAR AI Chair position, which provides significant research resources for advancing machine learning methodologies with scientific impact. Pleiss co-created and maintains GPyTorch, a highly efficient and modular implementation of Gaussian processes in PyTorch designed for speed, modularity, and prototyping. He is also involved with CoLA (Compositional Linear Algebra), a library for structured linear algebra operations in JAX and PyTorch that enables fast linear algebra computations by automatically exploiting matrix structure.

• Machine Learning
• Deep Learning
• Gaussian Processes
• +5 more

Dr. Stan Ahalt serves as the inaugural Dean of the UNC School of Data Science and Society (SDSS) and holds a professorship in the Department of Computer Science at UNC-Chapel Hill. He previously directed the Renaissance Computing Institute (RENCI) and currently acts as its executive advisor. Additionally, he is the associate director of informatics and data science at NC TraCS, the translational research institute at UNC. His academic journey includes a 22-year tenure as professor of electrical and computer engineering at Ohio State University and leadership roles at the Ohio Supercomputer Center. Ahalt’s research focuses on applying data science to societal challenges such as healthcare, climate, and judicial reform. Key initiatives include the National Consortium for Data Science and the iRODS project, which advanced enterprise data management systems. Ahalt has secured over $34.5M in grants to lead high-impact projects like the NHLBI BioData Catalyst (unifying biomedical data), the NCATS Translator (accelerating clinical discovery), and the NIH HEAL Initiative (ensuring FAIR data standards). He mentors students across doctoral and master’s programs, teaching data science fundamentals in courses like COMP 116: Introduction to Scientific Programming. His work emphasizes interdisciplinary collaboration, evidenced by roles in RENCI, NC TraCS, and the SDSS. Ahalt’s contributions span cyberinfrastructure development, educational innovation, and translational research, positioning UNC as a national leader in data science.

• Data Science
• High-Performance Computing
• Biomedical Informatics
• +4 more

Vikramaditya G. Yadav is an Associate Professor at the University of British Columbia (UBC) in the Department of Chemical and Biological Engineering, Faculty of Applied Science. He directs the Master of Engineering Leadership (MEL) Program in Sustainable Process Engineering and leads the BioFoundry research group. Education: B.A.Sc., University of Waterloo (2007) Ph.D., Massachusetts Institute of Technology (2013) Postdoctoral Associate, Harvard University (2014) His research spans sustainable chemical manufacturing, metabolic engineering, and biotechnology. Key areas include: Designing biosynthetic enzymes for biomass valorization Developing bioremediation strategies for industrial water quality Creating innovative drug delivery systems and tissue engineering solutions Advancing synthetic biology for pharmaceutical and bioenergy applications His recent work focuses on ocular drug delivery, cannabinoid biosynthesis in E. coli, lignin-based nanoparticles for cancer therapy, and computational analysis of plant secondary metabolites. Collaborations with start-ups, industry, and medical labs drive innovation in Canada's bioeconomy. Professional Leadership: Chair, Biotechnology Division of the Chemical Institute of Canada Associate Editor, The Canadian Journal of Chemical Engineering He is affiliated with UBC's BioProducts Institute and contributes to project-based learning pedagogy.

• Biocatalysis
• Bioremediation
• Bioprocess engineering
• +15 more

Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award

• 3D Printing
• Nanotechnology
• Biomedical Engineering
• +4 more

Kristian Helin is Chief Executive and President of The Institute of Cancer Research (ICR), London, and a Professor with affiliations at the University of Copenhagen and Memorial Sloan Kettering Cancer Center. He founded/directed the Biotech Research & Innovation Centre (BRIC), Centre for Epigenetics, and Danish Stem Cell Center. His research focuses on epigenetic regulation, cancer biology, and stem cell differentiation. Education: Ph.D. Molecular Biology, University of Copenhagen (1991) M.Sc. Chemical Engineering, Technical University of Denmark (1988) Research Interests: Helin's work deciphers molecular mechanisms in cancer, emphasizing epigenetic drivers (e.g., H3K4/H3K36 methylation), transcriptional control, and therapeutic targeting. His lab identified E2F transcription factors, linked epigenetic dysregulation to leukemia/lymphoma, and develops drugs targeting kinases/epigenetic enzymes. Research spans acute myeloid leukemia, B-cell lymphoma, and solid tumors using CRISPR screens and preclinical models. Publication Trends: Recent articles (2023-2025) focus on epigenetic therapy, chromatin remodeling, and kinase signaling in cancer. Key themes include targeting NSD1/KDM5C/RIOK2 enzymes, combination therapies (EZH2/DOT1L inhibitors), and metabolic regulation in leukemia. Studies bridge basic mechanisms (enhancer regulation, insulator accessibility) with translational applications. Awards: Anders Jahre Prize (2014), ERC Advanced Grant (2011), Novo Nordisk Prize (2008) Memberships: Academia Europaea, Royal Danish Academy, EMBO Leadership: Helin co-founded EpiTherapeutics (acquired by Gilead) and leads the Epigenetics and Cancer lab at ICR. His team investigates AML pathogenesis and chromatin complexes like HUSH/NURF. Grants include ERC funding and innovation prizes.

• Cancer biology
• Epigenetics
• Stem cells
• +5 more

Prof. Michael Moor is a tenure-track Assistant Professor for Medical AI at ETH Zurich's Department of Biosystems Science and Engineering in Basel. Previously, he conducted postdoctoral research at Stanford University under Prof. Jure Leskovec, focusing on medical foundation models. His work spans causal learning, multimodal AI, and sepsis prediction. Moor holds an MD from the University of Basel and a PhD from ETH Zurich's Machine Learning and Computational Biology Lab under Prof. Karsten Borgwardt. Research Interests: Generalist medical AI models Multimodal medical reasoning Zero-shot and few-shot learning Clinical causal inference Retrieval-augmented language models Sepsis prediction systems Key Achievements: Published foundational work in Nature (2023) on generalist medical AI Developed Med-Flamingo multimodal model (2023) Zero-shot causal learning framework accepted to NeurIPS 2023 (Spotlight) International sepsis prediction study with 156k ICU patients (2023) Lab Activities: Leads ETH's Medical Foundation Models group, collaborating with Stanford HAI and NASA Ames. Active in creating medical AI benchmarks like AgentClinic and developing retrieval-augmented systems like Almanac.

• Medical AI
• Machine Learning in Healthcare
• Causal Learning
• +3 more

Connor Coley is the Henri Slezynger (1957) Career Development Assistant Professor at the Massachusetts Institute of Technology (MIT) School of Engineering. His research bridges chemistry and machine learning, focusing on autonomous molecular discovery, predictive chemistry, and laboratory automation. Education: Ph.D., MIT (2019) M.S.CEP., MIT (2016) B.S., Caltech (2014) Research Interests: Dr. Coley’s work centers on domain-informed machine learning for chemistry, computer-aided molecular design, and autonomous laboratories. Key themes include predictive modeling of chemical reactivity, optimization of synthesis pathways, and integration of AI with experimental data for drug discovery and materials science. Publications: His recent articles highlight advancements in AI-driven reaction prediction, molecular representation learning, and laboratory automation. Trends include applications of Bayesian optimization, contrastive learning, and diffusion models to chemical discovery. Scientific Awards: Camille Dreyfus Teacher-Scholar Award (2025) James W. Swan Outstanding Faculty (2025) Schmidt Futures AI2050 Early Career Fellow (2022) NSF CAREER Award (2021) Forbes 30 Under 30: Healthcare (2019) Software & Tools: He leads the open-source ASKCOS software suite for synthesis planning, adopted by 35,000+ chemists and deployed at 15+ pharmaceutical companies. His team also develops tools for metabolomics and molecular representation learning.

• Machine Learning for Chemistry
• Computer-Aided Molecular Design
• Synthesis Planning
• +5 more

Thibault Mayor is a Professor in the Department of Biochemistry and Molecular Biology and the Michael Smith Laboratories at the University of British Columbia (Vancouver). His research focuses on understanding how cells manage misfolded proteins, with implications for neurodegenerative diseases like Parkinson's and Alzheimer's. He holds academic affiliations with the Centre for High-Throughput Biology (CHiBi) and has been recognized with awards including the UBC Killam Teaching Award (2020). Education: BSc, University of Geneva, Switzerland (1997) PhD, University of Geneva & Max Planck Institute of Biochemistry, Germany (2001) Postdoctoral Fellow, California Institute of Technology (2002) Research Interests: Mayor's lab investigates protein homeostasis, ubiquitin-proteasome system dynamics, and the molecular mechanisms underlying protein aggregation in aging and disease. Projects include proteomic approaches to identify aggregation-prone proteins and develop microbial cell factories for protein production. Grants & Awards: CIHR Project Grant ($730K, 2018) Michael Smith Foundation Career Award (2012) UBC Killam Teaching Award (2020) Labs & Collaborations: The Mayor Lab is part of the Michael Smith Laboratories and collaborates with computational biologists like Jörg Gsponer. They maintain active partnerships in proteomics and systems biology, contributing to initiatives like the BC Proteomics Network.

• Protein Homeostasis
• Ubiquitin Proteasome System
• Neurodegenerative Diseases
• +7 more

David John Procter is a Professor of Organic Chemistry and Head of the Department of Chemistry at the University of Manchester. His career includes academic roles at the University of Glasgow (Lecturer, Senior Lecturer) and a Readership at the University of Manchester, where he became a Professor in 2008. His research focuses on developing new synthetic methods, catalysis, and materials chemistry, with applications in drug discovery, biocatalysis, and organic electronics. Education: BSc Chemistry (University of Leeds, 1992), PhD (1995, supervised by Prof. Christopher Rayner). Postdoctoral work: Florida State University (Prof. Robert Holton, Taxol analog synthesis). Research interests include samarium diiodide-mediated reactions, metal-free coupling processes, and sustainable synthesis methods. He leads projects funded by EPSRC, Industry (30 grants), and international collaborations. Awards include the EPSRC Established Career Fellowship (2015–2020), Bader Prize (2014), and Young Heterocyclic Chemist Award (2015). Key contributions: Total synthesis of natural products (e.g., pleuromutilin), development of copper-catalyzed multicomponent couplings, and innovative methods for organic materials. His work aligns with UN Sustainable Development Goals related to affordable and clean energy and responsible consumption. Collaborations span academic and industrial partnerships in chemistry, physics, and biology. He supervises 60+ students and contributes to the Organic Materials Innovation Centre (OMIC). His group’s research is detailed at proctergroupresearch.com .

• Organic Synthesis
• Catalysis
• New Synthetic Methods
• +5 more

David H. Sherman is the Hans W. Vahlteich Professor of Medicinal Chemistry at the University of Michigan, holding joint appointments in the College of Pharmacy (Department of Medicinal Chemistry), Medical School (Microbiology & Immunology), and College of Literature, Science, and the Arts (Chemistry). He leads the Sherman Lab at the Life Sciences Institute and co-founded the Natural Products Discovery Core. His research focuses on natural product discovery, biosynthetic pathways, and drug development for infectious diseases, cancer, and neurological disorders. Education: PhD in Synthetic Organic Chemistry from Columbia University (1981), BA in Chemistry from UC Santa Cruz (1978). Postdoctoral research at MIT (1984). Research interests include microbial secondary metabolites, enzymatic catalysis (e.g., C-H functionalization, polyketide assembly), and high-throughput drug screening. He pioneered a microbial natural product library with over 50,000 samples. Current projects emphasize developing macrolide antibiotics and advancing compounds toward clinical trials through the Natural Products Biosciences Initiative. Collaborations span global institutions, with a focus on biodiversity conservation and capacity-building in low-income nations. He has mentored 67 PhD students, 60 postdocs, and 85+ undergraduates, fostering interdisciplinary training in chemical biology and microbial biochemistry. Labs/Teams: Sherman Lab (Life Sciences Institute), Center Member at Samuel and Jean Frankel Cardiovascular Center, Center for Computational Medicine and Bioinformatics, Rogel Cancer Center.

• Natural Products Chemistry
• Medicinal Chemistry
• Biosynthesis
• +4 more

Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.

• Small Molecule Drug Discovery
• Cancer Therapeutics
• Pharmaceutical Chemistry
• +3 more

Wengong Jin is an Assistant Professor at the Khoury College of Computer Sciences, Northeastern University, and a visiting research scientist at the Eric and Wendy Schmidt Center at the Broad Institute. He holds a PhD from MIT CSAIL, advised by Prof. Regina Barzilay and Prof. Tommi Jaakkola. Research Interests: His work focuses on geometric and generative AI models for drug discovery, biology, and chemical engineering. Key areas include equivariant neural networks (e.g., FAFormer), diffusion models for binding energy prediction, antibody/enzyme design (RefineGNN, SurfPro), and molecular design through graph neural networks (Junction Tree VAE). He also explores domain generalization and systems for autonomous molecular discovery. Publications: His research has been published in top venues like NeurIPS, ICLR, ICML, Nature, Science, and Cell. Recent breakthroughs include discovering novel antibiotics using explainable AI and designing synergistic drug combinations for cancer treatment. Awards: He has received the BroadIgnite Award, Dimitris N. Chorafas Prize, and MIT EECS Outstanding Thesis Award for his contributions to computational biology and AI-driven drug discovery. Teaching: Currently teaches a PhD seminar on AI for Science, focusing on integrating machine learning into scientific discovery processes.

• AI for drug discovery
• Generative AI models
• Geometric deep learning
• +5 more